MedPath

Correlation of Genetic Polymorphisms and Clinical Parameters With the Complexity of Coronary Artery Disease

Conditions
Coronary Arteriosclerosis
Coronary Artery Disease
Cardiovascular Risk Factor
Interventions
Genetic: SNPs associated with CAD
Registration Number
NCT03315234
Lead Sponsor
Aristotle University Of Thessaloniki
Brief Summary

The purpose of the research project is to investigate the potential association of 6 genetic polymorphisms with the complexity and the severity of coronary artery disease (SYNTAX score). The aim of the study is to combine genetic, clinical and laboratory data in order to create a prognostic tool that will enable an individualized therapeutic patient approach.

Detailed Description

This study focus on the prediction of future risk of cardiovascular events, assessing the severity and complexity of coronary artery disease by incorporating genetic information into the SYNTAX score and providing personalized therapeutic guidance to patients. The ultimate goal of the study would be to identify, design and develop a panel of genetic markers that in combination with clinical and angiographic information will be a reliable tool for predicting cardiovascular risk for future adverse events. Clinical and genetic patient information are systematically collected in a fashion that will enable also retrospective evaluation.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
270
Inclusion Criteria
  1. Patients who are admitted in the Department of Cardiology in the AHEPA University General Hospital of Thessaloniki and undergo coronary angiography for clinical purposes
  2. Patients giving voluntary written consent to participate in the study
  3. Male or female patients between 18 years to 90 years at entry
  4. Patients without previous history of CAD
Exclusion Criteria
  1. Patients < 18 years old and > 90 years old at time of coronary angiography
  2. Patients with a previous history of CAD
  3. Cardiac Arrest at admission
  4. Patients with serious concurrent disease and life expectancy of < 1 year
  5. Patients who refuse to give written consent for participation in the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
0 < SYNTAX score < 23SNPs associated with CADLow SYNTAX group
SYNTAX score = 0SNPs associated with CADPatients with nonobstructive CAD (≤50 % diameter stenosis)
SYNTAX score ≥ 23SNPs associated with CADIntermediate-High SYNTAX group
Primary Outcome Measures
NameTimeMethod
Relationship between genetic risk variants and the SYNTAX score [All-comers population]12 months

The investigators will evaluate the effects of 6 known genetic variants associated with risk of Coronary Artery Disease on the extend and severity of coronary atherosclerosis \[as assessed by the SYNTAX score\] in patients with significant CAD on coronary angiography, both individually and combined in a Genetic Risk Score

Secondary Outcome Measures
NameTimeMethod
Mean Platelet VolumeAt hospital admission

MPV \[fL\]

High Density LipoproteinAt hospital admission

HDL \[mg/dL\]

Glomerular Filtration RateAt hospital admission

GFR as assessed by CKD-EPI formula \[mL/min/1.73m²\]

MACCEs12 months

Cardiovascular death, myocardial infarction, stent thrombosis, any re-intervention and stroke

Predictive value of combining a Genetic Risk Score & SYNTAX score for the prediction of 1-year MACCEs12 months

A Genetic Risk Score will be calculated as the weighted sum of alleles of 6 single nucleotide polymorphisms previously associated with CAD \[The GRS will be constructed by summing the number of risk alleles (0/1/2) for each of the 6 SNPs weighted by their estimated effect sizes\].

SYNTAX score is a coronary lesion complexity scoring system and represented by a single number.

Ankle-Brachial IndexAt hospital admission

A tool for diagnosing peripheral artery disease but also an indicator of systemic atherosclerosis \[represented by a single number\]

Left Ventricular Ejection FractionAt hospital admission & 12 months after discharge from hospital

LVEF \[%\] as assessed by echocardiography

Neutrophil to Lymphocyte RatioAt hospital admission

NLR \[represented by a single number\]

Red Cell Distribution WidthAt hospital admission

RDW \[%\]

Trial Locations

Locations (1)

AHEPA University Hospital

🇬🇷

Thessaloníki, Greece

© Copyright 2025. All Rights Reserved by MedPath